ARCA biopharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1992-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.arcabio.com
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Phase 2
Completed
- Conditions
- Arterial Occlusive DiseasesPeripheral Vascular DiseasesThrombosis
- First Posted Date
- 2003-11-26
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00073554
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
Phase 2
Completed
- Conditions
- Catheters, Indwelling
- First Posted Date
- 2003-11-25
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT00073515
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath